In the news

August 26, 2019

Structural Biology Used to Gain Insight into the Mechanism of Action of Covalent Inhibitors of the Deubiquitinase UCHL1

The insight into mechanism of action and structural analysis learned from this work provides information for the future design of potent and selective UCHL1 covalent inhibitors.

August 20, 2019

‘A first for cancer research’: New approach to study tumors

Sophie Lelièvre, a professor of cancer pharmacology at Purdue University, is leading a team of scientists to create tumor models in 10 days that are much closer in size to the ones found in the body and readily mimic the pathological characteristics of human cancers.

New anticancer agents have potential to better control tumor growth in nearly every cancer type

Novel set of G-quadruplex stabilizers may help stop gene from driving tumor growth in hundreds of cancers

Purdue ranks 12th among worldwide universities granted U.S. utility patents for 2018

Purdue receives 126 U.S. utility patents, finishing in the top 20 for fifth straight year

Tyler Trent’s donated cells to help trio of new research projects

Purdue University superfan’s legacy lives on through cancer collaborations

January 28, 2019

Legislation to support cancer research passes Senate

Senate Bill 66 would add an additional item to this list, giving Hoosiers the opportunity to put their income tax refund towards cancer research at the Indiana University Simon Cancer Center and the Purdue Center for Cancer Research.